HomeBUSINESS
BUSINESS

Foreign Players’ Japan Sales Hit Plateau as 11 Firms See Paltry 0.2% Rise; Pfizer, Boehringer Falter
(Jun.20.2018)

By Reiji Anasako

Japan sales of foreign drug makers appear to have leveled off in 2017 as 11 companies barely delivered an average revenue rise, at just 0.2%, with Pfizer and Nippon Boehringer Ingelheim battered by generic erosions into their mainstay portfolios, a Jiho tally revealed ...
(LOG IN FOR FULL STORY)

News Calendar